Quell Therapeutics
PrivateLast Round
Strategic
Jun 9, 2023
Est. Valuation
$34.09M
Total Funding Raised
$405.4M
Company Overview
Quell Therapeutics is a biotechnology company that develops engineered T-regulatory (Treg) cell therapies to treat severe immune-mediated and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Quell Therapeutics Comparables
Compare Quell Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sonoma Biotherapeutics | 88% | |
| GentiBio | 84% | |
| ActiTrexx GmbH | 83% | |
Quell Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jun 9, 2023 | ||||
| Series B | Nov 29, 2021 | ||||
| Series A Extension | Feb 11, 2021 | ||||
| Series A | May 20, 2019 | ||||
| Series A | Mar 29, 2019 |
Quell Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series B |
| SV Health Investors | Series B |
| Syncona | Series B, Series A, Series A Extension |
| Ridgeback Capital | Series B |
| Future Fund | Series B |
| Fidelity Management & Research Company | Series B |
| British Patient Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 25, 2025
Presenting data at ACR Convergence 2025.
- Oct 25, 2025
Will present data for QEL-005 CAR-Treg cell therapy at ACR Convergence 2025.
Quell Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Quell Therapeutics's valuation, stock price, and market status.